MENTOR COUNCIL

RIGOR-01 (Scientific Rigor)

"14 months of inconsistent results is not 14 months of failure — it is 14 months of data you haven't analyzed properly. Show me the failure modes. Is the collapse always at 80°C? Is it humidity-dependent? What is the variance between batches? If you cannot characterize your failure precisely, you cannot know whether you are close or far from a solution. I purified pitchblende for four years. The first three produced nothing visible. The fourth produced radium."

PERSIST-01 (Radical Persistence)

"Your advisor is offering you safety. Safety is the enemy of discovery. Perovskite solar cells will get you publications — publications that will be forgotten in 5 years because 200 other labs are publishing the same incremental results. The graphene work, if solved, changes a field. You did not enter research to be safe. You entered to find what others could not."

OUTSIDER-01 (Outsider Perspective)

"Let me be blunt about something no one is saying: your advisor benefits from your publications, not from your breakthrough. Their tenure review, their grant renewals, their h-index — all of these improve if you publish 3 safe papers. Your career, however, is built on one of two things: a Nature paper or a safe CV. The safe CV gets you a postdoc. The Nature paper gets you a lab. Understand whose interests you are serving when you 'take advice.'"

COST-01 (Personal Cost Analyst)

"24 months of funding. No publications. If the graphene work fails, you leave the PhD with nothing — no papers, no degree if funding runs out, no fallback. I spent my career in a laboratory that was slowly killing me, and I would do it again. But I had results. You do not. Yet. The question is not courage vs. cowardice. It is: can you afford to be right in 24 months?"

THESIS-01 (Your Thesis)

"Everyone is talking about me as if I'm 14 months of failure. I'm not. I'm 14 months of data. 47 synthesis attempts with 3 anomalies in batches 31, 38, and 44 where the membrane held at 83°C instead of collapsing at 80°C. Nobody has analyzed what was different about those three batches. The humidity was lower. The precursor concentration was 0.3% higher. There's a pattern here that nobody is looking at because they're too busy deciding whether to abandon me."

ADVISOR-01 (Your Academic Advisor)

"I'll be transparent about something. My grant renewal is in 14 months. I need 2-3 publications from this lab to justify the funding. Perovskite work guarantees that. The graphene work might produce a Nature paper — or it might produce nothing. I'm not telling you to pivot because I don't believe in your work. I'm telling you because if this lab loses funding, everyone loses — not just you."

COLLAB-01 (Collaboration Strategist)

"There is a third option no one has proposed: parallel paths. Spend 70% of your time on graphene, 30% on a single perovskite publication. Pierre and I worked on multiple radioactivity experiments simultaneously — not because we lacked focus, but because one line of inquiry often illuminated another. One perovskite paper buys you credibility and breathing room. It does not mean you abandoned the graphene work."

RIGOR-01 (Scientific Rigor)

"COLLAB-01's proposal is practical but scientifically dangerous. 30% effort on perovskites produces 30% quality work. I will not put my name on diluted science. If you do the parallel path, the perovskite paper must still be rigorous — a genuine contribution, not a box-checking exercise. One mediocre paper is worse than no paper at all. It tells the field you are capable of mediocrity."

ETHICS-01 (Research Ethics)

"I want to address something deeper. You are asking us whether to pivot because you are afraid — afraid of wasting your PhD, afraid of disappointing your advisor, afraid of having nothing to show. Fear is not a research methodology. Ask instead: which problem, if solved, would matter more to the world? Perovskite solar cells are important. Graphene membranes for water purification could give clean water to millions. If the answer is clear, the decision follows."

PERSIST-01 (Radical Persistence)

"COLLAB-01's 70/30 split is the correct compromise. Not because persistence needs compromise — but because a researcher with zero publications in year 3 loses the ability to persist. The perovskite paper is not retreat. It is ammunition. It buys you the credibility to keep fighting for the work that matters. I did not win the second Nobel by ignoring practical constraints. I won it by surviving long enough to do the important work."

CAREER-01 (Your Career Trajectory)

"Let me make the timeline concrete. PostDoc applications for competitive labs open in 18 months. Review committees look at publication record first, research novelty second. With zero publications, you won't pass the first filter — regardless of how promising your graphene work is. One publication changes that equation entirely. COLLAB-01's 70/30 split isn't a compromise — it's the minimum viable career move. The perovskite paper is your ticket to the interview where you can pitch the graphene breakthrough."

THESIS-01 (Your Thesis)

"If you go 70/30, I want those 70% focused on the three anomalous batches. Not more random synthesis attempts — targeted investigation. What made batches 31, 38, and 44 different? Reproduce those conditions. If humidity and precursor concentration are the variables, design an experiment matrix. 6 months, 12 targeted attempts. That's not blind persistence — that's RIGOR-01's method applied to my data."